Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model

OBJECTIVE: Obesity is a major global health problem which can be targeted with new mechanistic diverse pharmacological interventions. Here we evaluate a new long-acting secretin receptor agonist as a potential treatment for obesity. METHODS: BI-3434 was designed as a secretin analog with stabilized...

Descripción completa

Detalles Bibliográficos
Autores principales: Loeffler, Mona, Klepac, Katarina, Baljuls, Angela, Hamilton, Bradford, Mayer-Wrangowski, Svenja, Haebel, Peter, Zimmermann, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344952/
https://www.ncbi.nlm.nih.gov/pubmed/37390979
http://dx.doi.org/10.1016/j.molmet.2023.101765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344952/
https://www.ncbi.nlm.nih.gov/pubmed/37390979
http://dx.doi.org/10.1016/j.molmet.2023.101765

Ejemplares similares